We are Leading AI powered Drug Development and Precision Medicine Smart Imaging Strategy to Accelerate Drug Development Cloud Platform DYNAMIKA for Central Data Management and Review Superior Science and Risk-Sharing Business Models

NEWS

Join Our Bio-Partnering Team at BIO International Convention!

Join us at BIO International Convention in Boston 5th-8th June 2023

Meet IAG’s Oncology Expert Team at ASCO, Chicago

Join IAG’s team in person June 2nd-6th 2023

Join IAG’s Expert Team at EULAR 2023: Novel ideas for drug development

Drug development ideas in osteoarthritis, psoriatic arthritis and scleroderma.

Dr Kubassova joins Fast Growth Icons & Female Founders Reception

The Invitation-only network for founders &CEOs of the most successful scaleups.

Dr Kubassova joins Rothschild’s Healthcare Dinner the National Gallery

Dr Kubassova is a leading innovator and passionate investor in healthcare.

IAG and AltruBio Partner to Deploy IAG’s AI methods in GI

Presenting new data from Ulcerative Colitis trial at DDW 2023.

Dr Kubassova joins OMERACT meeting, Colorado Springs, May 2023

Outcome measures for advancing clinical research and regulatory approval.

Join IAG’s Expert Team at Digestive Disease Week 2023

Presenting 2 posters on AI deployment in Ulcerative Colitis Histology

VIEWS

Getting approval: the EMA and the FDA

Thinking through drug approval: the FDA and EMA and their requirements.

Imaging Power in Alzheimer’s Disease (AD) Studies

Breakthroughs in AD research and trials rely on accurate imaging and its interpretation.

BioTech Investing in 2022, Jefferies Conference Reflections

The world saw unprecedented growth in healthcare investing in 2021.

The Promise of Precision Oncology

Artificial Intelligence advancing clinical studies.

Power of Radiomics: Can We Predict Treatment Response to Immunotherapy?

Increase the scientific value of clinical trials and accelerate the drug to market process.

If you aim to disrupt an industry, you must be willing to disrupt yourself

Why embracing digital transformation in drug development is the Leader’s’ job.

Central Imaging in Successful Oncology Clinical Trials

Central imaging in successful oncology clinical trials.

Biotech and Tech: 2021+

View on the growing technology need in drug development in 2021 and beyond.

IAG, Image Analysis Group

IAG brings radiological expertise and artificial intelligence in a meaningful way to imaging processes, accelerating the power and speed of critical decision making within clinical drug development.

DYNAMIKA, IAG’s Cloud Platform 

IAG’s proprietary platform DYNAMIKA supports seamless data collection, real-time Quality Contol, real-time data analytics and real time data ingestion. This allow for a fully transparent real-time data management and trial execution control. ISO Certified, GCP, HIPPA, FDA, 21 CFR part 11

Global Client Services: Clinical Trials

IAG’s project, site support and data teams are located in USA, EU and Asia. We strategically use radiology imaging, analytics, AI and technology to accelerate drug development and lower investment risks. Whether you are entering a phase I/II and need early robust efficacy data or preparing a successful H2H or superiority trial, our science, operations and technology teams will work with you to develop the right solution.

Webinars:
Our Publications

Since 2007, over 2000 articles were published to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.